Free Trial
NYSE:INSP

Inspire Medical Systems Q1 2025 Earnings Report

Inspire Medical Systems logo
$159.89 +1.99 (+1.26%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$159.57 -0.32 (-0.20%)
As of 04:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Upcoming Event
Earnings Conference Call
Inspire Medical Systems Q1 2025
00:00 / 00:00
Live Transcript
Follow Audio

Inspire Medical Systems EPS Results

Actual EPS
N/A
Consensus EPS
-$0.23
Beat/Miss
N/A
One Year Ago EPS
N/A

Inspire Medical Systems Revenue Results

Actual Revenue
N/A
Expected Revenue
$194.89 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Inspire Medical Systems Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Monday, May 5, 2025
Conference Call Time
5:00PM ET

Conference Call Resources

Inspire Medical Systems Earnings Headlines

Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
See More Inspire Medical Systems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Inspire Medical Systems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inspire Medical Systems and other key companies, straight to your email.

About Inspire Medical Systems

Inspire Medical Systems (NYSE:INSP), a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

View Inspire Medical Systems Profile

More Earnings Resources from MarketBeat